Court Rebukes Agency For Not Completing Probe Against Jet Airways' Naresh Goyal
The Bombay High Court on Tuesday rebuked the Serious Fraud Investigation Office (SFIO) for not completing its probe against Jet Airways founder Naresh Goyal and his wife in a case of an alleged Rs 7,000 crore fraud.
A division bench of Justices Revati Mohite Dere and Sharmila Deshmukh expressed displeasure about the tardy pace of probe while allowing Naresh Goyal's wife Anita to travel to the United Arab Emirates for a month on April 20.
Naresh Goyal, however, failed to get a similar permission as the court said it could not hear his application in detail due to paucity of time.
The couple had moved the court seeking permission to travel abroad.
The SFIO, which falls under the jurisdiction of the Corporate Affairs Ministry, said it was opposed to the couple traveling together, but had no objection if Anita Goyal were to travel alone.
Advocate Hiten Venegaonkar, appearing for the central agency, told the court that the investigation against the Goyals, initiated in 2019, was still underway and was likely to be concluded by September 2023.
This drew sharp comments from the high court.
"Your investigation is going on since 2019. You have to take your investigation to some logical end. Somewhere there has to be a closure in cases. You cannot go on endlessly with investigation," Justice Dere said.
Venegaonkar said the alleged fraud was of a huge magnitude, and Naresh Goyal was not extending his full co-operation.
The court then remarked that the SFIO must have able and efficient officers.
While permitting Anita Goyal to travel, the court suspended all the Look Out Circulars issued against her for a month.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.